Family and friends' fears of recurrence: impact on the patient's recovery after subarachnoid hemorrhage Clinical article

被引:2
|
作者
Covey, Judith [1 ]
Noble, Adam J. [2 ]
Schenk, Thomas [3 ]
机构
[1] Univ Durham, Dept Psychol, Stockton On Tees TS17 6BH, England
[2] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London, England
[3] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany
关键词
subarachnoid hemorrhage; caregiver; psychosocial domain; recovery; fear; recurrent hemorrhage; vascular disorders; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; PSYCHOSOCIAL OUTCOMES; CARERS; PREDICTORS; ADJUSTMENT; VARIABLES; ANEURYSMS; BREAST; CANCER;
D O I
10.3171/2013.5.JNS121688
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Patients with subarachnoid hemorrhage (SAH) and their close friends and family may be excessively fearful that the patient will have a recurrence, and such fears could play a critical role in the poor recovery shown by many patients The authors examined whether these fears could account for significant variance in psychosocial outcomes. Methods. The authors prospectively studied a sample of 69 patients with SAH alongside their spouse, other family member, and/or close friend identified as their significant other (SO). The patient/SO pairs were assessed at 13 months postictus for their fears of recurrence and for health-related quality of life on the 8 domains of the 36-Item Short Form Health Survey. Results. The SOs were found to be significantly more fearful of SAH recurrence than the patients. The SO's fears also explained unique variance in the patient's recovery on 4 of the 36-Item Short Form Health Survey domains over and above the patient's own fears, demographic and/or neurological variables;and the patient's history of psychiatric or neurological problems. The domains affected reflected activity-based and functional aspects of the patient's quality of life as opposed to more general characteristics of their emotional well-being or physical health state. Conclusions. The patient's recovery may be compromised if their spouse, close family, and/or friends are excessively fearful about their suffering a recurrence. Perhaps the SO's fears cause them to be overprotective of the patient and to restrict their day-to-day activities. Attention must therefore be given to the experience of having a loved one suffer from an SAH, and alleviating the caregiver's fears could help to promote a better outcome for the patient.
引用
收藏
页码:948 / 954
页数:7
相关论文
共 26 条
  • [21] Risk Factors and Clinical Impact of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: Analysis from the China National Stroke Registry
    Duan, Wanying
    Pan, Yuesong
    Wang, Chunjuan
    Wang, Yilong
    Zhao, Xingquan
    Wang, Yongjun
    Liu, Liping
    NEUROEPIDEMIOLOGY, 2018, 50 (3-4) : 128 - 136
  • [22] The Impact of Endovascular Rescue Therapy on the Clinical and Radiological Outcome After Aneurysmal Subarachnoid Hemorrhage: A Safe and Effective Treatment Option for Hemodynamically Relevant Vasospasm?
    Mielke, Dorothee
    Doering, Katja
    Behme, Daniel
    Psychogios, Marios Nikos
    Rohde, Veit
    Malinova, Vesna
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [23] Conversion of external ventricular drains to ventriculoperitoneal shunts after aneurysmal subarachnoid hemorrhage: effects of site and protein/red blood cell counts on shunt infection and malfunction Clinical article
    Rammos, Stylianos
    Klopfenstein, Jeffrey
    Augsburger, Lori
    Wang, Huan
    Wagenbach, Anne
    Poston, Jennifer
    Lanzino, Giuseppe
    JOURNAL OF NEUROSURGERY, 2008, 109 (06) : 1001 - 1004
  • [24] Psychosocial and neurocognitive performance after spontaneous nonaneurysmal subarachnoid hemorrhage related to the APOE-ε4 genotype: a prospective 5-year follow-up study Clinical article
    Alfieri, Alex
    Unterhuber, Vera
    Pircher, Martina
    Schwarz, Andreas
    Gazzeri, Roberto
    Reinert, Michael
    Widmer, Hans R.
    JOURNAL OF NEUROSURGERY, 2008, 109 (06) : 1019 - 1026
  • [25] Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]
    Haenggi, Daniel
    Etminan, Nima
    Mayer, Stephan A.
    Aldrich, E. Francois
    Diringer, Michael N.
    Schmutzhard, Erich
    Faleck, Herbert J.
    Ng, David
    Saville, Benjamin R.
    Macdonald, R. Loch
    NEUROCRITICAL CARE, 2019, 30 (01) : 88 - 97
  • [26] Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]
    Daniel Hänggi
    Nima Etminan
    Stephan A. Mayer
    E. Francois Aldrich
    Michael N. Diringer
    Erich Schmutzhard
    Herbert J. Faleck
    David Ng
    Benjamin R. Saville
    R. Loch Macdonald
    Neurocritical Care, 2019, 30 : 88 - 97